… childhood acute lymphoblastic leukemia (ALL), the risk of relapse remains about 30 percent.
Studies have shown that the presence or absence of residual disease, … of residual leukemic …

… Minimal residual disease (MRD) is an important predictor of relapse in acute lymphoblastic
leukemia … The Children's Oncology Group studied the prognostic impact of MRD measured by …

… Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.
… prior to stem cell transplant for childhood acute lymphoblastic leukaemia. Br J Haematol …

… predicts relapse in acute lymphoblastic leukemia (ALL). We examined the clinical significance
of levels below the usual threshold value for MRD positivity (0.01%) in 455 children with B-…

… detecting one leukemic cell in 10 4 normal cells, we prospectively … minimal residual disease
(MRD) in 195 children with newly diagnosed acute lymphoblastic leukemia (ALL) in clinical …

… Reducing the need for a diversified investigative setup should add to the clinical
significance of FC also by augmenting its economic efficiency. We suggest that a methodologic …

… acute lymphoblastic leukemia (ALL), treatment response is increasingly evaluated with minimal
residual disease (… The clinical significance of MRD has been conclusively demonstrated …

… Adult patients with acute lymphoblastic leukemia (ALL) who are stratified into the standard-…
ALL, we evaluated the predictive value of minimal residual disease (MRD) and prospectively …

… clinical significance of recently identified subtypes of acute lymphoblastic leukemia (ALL) in
598 children treated with minimal residual disease (MRD)–directed therapy. Among the 16 B-…

… minimal residual disease (MRD) can determine the response to treatment in patients with
acute lymphoblastic leukemia (… The clinical significance of MRD, detected by flow cytometry or …